Gyre Therapeutics (GYRE) EBITDA (2010 - 2026)
Gyre Therapeutics' EBITDA was -$12.88 million in Q2 2026, compared with -$1.23 million a year earlier.
Powered by 
Analysis
Gyre Therapeutics (GYRE) EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gyre Therapeutics' EBITDA was -$13.58 million through Jun 30, 2026; for FY2025, it was $13.97 million, down 21.1% from FY2024.
- In earlier years, EBITDA was $17.71 million in FY2024, -$66.16 million in FY2023, $10.29 million in FY2022 and -$87.6 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q4 2023.
- Compared with a year earlier, EBITDA was higher in 1 of the last four quarters, with an average decline of 27.0%.
- Per Business Quant data, GYRE's EBITDA in the three quarters before Q2 2026 was -$8.68 million (Q1 2026), $774,000 (Q4 2025) and $7.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.56 Bn | 1,141.15 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 637.42 Bn | 555.95 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 504.13 Bn | 477.24 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 377.81 Bn | 332.19 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 304.36 Bn | 268.35 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.51 Bn | 241.20 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 242.18 Bn | 197.58 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.29 Bn | 168.48 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.82 Bn | 119.47 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Gyre Therapeutics | 595.00 Mn | 363.15 Mn | 26.90 Mn | -12.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.88 Mn |
| Mar 31, 2026 | -8.68 Mn |
| Dec 31, 2025 | 774,000.00 |
| Sep 30, 2025 | 7.21 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | 2.81 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | -91.32 Mn |
| Sep 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 5.29 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | -21.59 Mn |
| Sep 30, 2022 | -5.13 Mn |
| Jun 30, 2022 | 51.60 Mn |
| Mar 31, 2022 | -14.59 Mn |
| Dec 31, 2021 | -20.20 Mn |
| Sep 30, 2021 | -25.14 Mn |
API Access
Gyre Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();